<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39025463</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-820X</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Virologica Sinica</Title><ISOAbbreviation>Virol Sin</ISOAbbreviation></Journal><ArticleTitle>Baicalein suppresses Coxsackievirus B3 replication by inhibiting caspase-1 and viral protease 2A.</ArticleTitle><Pagination><StartPage>685</StartPage><EndPage>693</EndPage><MedlinePgn>685-693</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virs.2024.07.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1995-820X(24)00113-5</ELocationID><Abstract><AbstractText>Myocarditis is an inflammatory disease of the cardiac muscle and one of the primary causes of dilated cardiomyopathy. Group B coxsackievirus (CVB) is one of the leading causative pathogens of viral myocarditis, which primarily affects children and young adults. Due to the lack of vaccines, the development of antiviral medicines is crucial to controlling CVB infection and the progression of myocarditis. In this study, we investigated the antiviral effect of baicalein, a flavonoid extracted from Scutellaria baicaleinsis. Our results demonstrated that baicalein treatment significantly reduced cytopathic effect and increased cell viability in CVB3-infected cells. In addition, significant reductions in viral protein 3D, viral RNA, and viral particles were observed in CVB3-infected cells treated with baicalein. We found that baicalein exerted its inhibitory effect in the early stages of CVB3 infection. Baicalein also suppressed viral replication in the myocardium and effectively alleviated myocarditis induced by CVB3 infection. Our study revealed that baicalein exerts its antiviral effect by inhibiting the activity of caspase-1 and viral protease 2A. Taken together, our findings demonstrate that baicalein has antiviral activity against CVB3 infection and may serve as a potential therapeutic option for the myocarditis caused by enterovirus infection.</AbstractText><CopyrightInformation>Copyright © 2024 The Authors. Publishing services by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Yanyan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Enze</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Siwei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ruiqi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lixin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Yingxia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luan</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Lexun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Zhaohua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150081, China. Electronic address: zhongzh@hrbmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Wenran</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin 150081, China. Electronic address: zhaowr@hrbmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virol Sin</MedlineTA><NlmUniqueID>101514185</NlmUniqueID><ISSNLinking>1995-820X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>49QAH60606</RegistryNumber><NameOfSubstance UI="C006680">baicalein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044950">Flavanones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.36</RegistryNumber><NameOfSubstance UI="D020170">Caspase 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.29</RegistryNumber><NameOfSubstance UI="C057400">picornain 2A, Picornavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D044950" MajorTopicYN="Y">Flavanones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="Y">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020170" MajorTopicYN="Y">Caspase 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D031364" MajorTopicYN="N">Scutellaria baicalensis</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003588" MajorTopicYN="N">Cytopathogenic Effect, Viral</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2A protease</Keyword><Keyword MajorTopicYN="N">Baicalein</Keyword><Keyword MajorTopicYN="N">Caspase-1</Keyword><Keyword MajorTopicYN="N">Coxsackievirus B (CVB)</Keyword><Keyword MajorTopicYN="N">Myocarditis</Keyword></KeywordList><CoiStatement>Conflict of interest The authors declare that there is no conflict of interests in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>24</Day><Hour>16</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>19</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>18</Day><Hour>19</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39025463</ArticleId><ArticleId IdType="pmc">PMC11401470</ArticleId><ArticleId IdType="doi">10.1016/j.virs.2024.07.003</ArticleId><ArticleId IdType="pii">S1995-820X(24)00113-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akao T., Kawabata K., Yanagisawa E., Ishihara K., Mizuhara Y., Wakui Y., Sakashita Y., Kobashi K. Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J. Pharm. Pharmacol. 2000;52:1563–1568.</Citation><ArticleIdList><ArticleId IdType="pubmed">11197087</ArticleId></ArticleIdList></Reference><Reference><Citation>Anirudhan V., Lee H., Cheng H., Cooper L., Rong L. Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19. J. Med. Virol. 2021;93:2722–2734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014870</ArticleId><ArticleId IdType="pubmed">33475167</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J., Thibaut H.J., Strating J.R.P.M., van Kuppeveld F.J.M. The life cycle of non-polio enteroviruses and how to target it. Nat. Rev. Microbiol. 2018;16:368–381.</Citation><ArticleIdList><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., Horwitz M.S., Crowell R.L., Finberg R.W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997;275:1320–1323.</Citation><ArticleIdList><ArticleId IdType="pubmed">9036860</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonderoff J.M., Lloyd R.E. CVB translation: lessons from the polioviruses. Curr. Top. Microbiol. Immunol. 2008;323:123–147.</Citation><ArticleIdList><ArticleId IdType="pubmed">18357768</ArticleId></ArticleIdList></Reference><Reference><Citation>Bopegamage S., Berakova K., Gomocak P., Baksova R., Galama J., Hyoty H., Tauriainen S. Primary site of Coxsackievirus B replication in the small intestines: no proof of Peyer's patches involvement. Microorganisms. 2021;9:2600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8709031</ArticleId><ArticleId IdType="pubmed">34946201</ArticleId></ArticleIdList></Reference><Reference><Citation>Chagas M.D.S.S., Behrens M.D., Moragas-Tellis C.J., Penedo G.X.M., Silva A.R., Gonçalves-de-Albuquerque C.F. Flavonols and flavones as potential anti-inflammatory, antioxidant, and antibacterial compounds. Oxid. Med. Cell. Longev. 2022;2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9470311</ArticleId><ArticleId IdType="pubmed">36111166</ArticleId></ArticleIdList></Reference><Reference><Citation>Chau D.H., Yuan J., Zhang H., Cheung P., Lim T., Liu Z., Sall A., Yang D. Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1. Apoptosis. 2007;12:513–524.</Citation><ArticleIdList><ArticleId IdType="pubmed">17195095</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung M., Andreoletti L., N'Guyen Y., Soize S., Bani-Sadr F., Hentzien M. Acute Coxsackievirus B3-induced meningo-cerebellitis in an immunocompetent adult patient. J. Neurovirol. 2022;28:619–621.</Citation><ArticleIdList><ArticleId IdType="pubmed">36194360</ArticleId></ArticleIdList></Reference><Reference><Citation>Diep J., Ooi Y.S., Wilkinson A.W., Peters C.E., Foy E., Johnson J.R., Zengel J., Ding S., Weng K.F., Laufman O., Jang G., Xu J., Young T., Verschueren E., Kobluk K.J., Elias J.E., Sarnow P., Greenberg H.B., Hüttenhain R., Nagamine C.M., Andino R., Krogan N.J., Gozani O., Carette J.E. Enterovirus pathogenesis requires the host methyltransferase SETD3. Nat. Microbiol. 2019;4:2523–2537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6879830</ArticleId><ArticleId IdType="pubmed">31527793</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaaloul I., Riabi S., Harrath R., Hunter T., Hamda K.B., Ghzala A.B., Huber S., Aouni M. Coxsackievirus B detection in cases of myocarditis, myopericarditis, pericarditis and dilated cardiomyopathy in hospitalized patients. Mol. Med. Rep. 2014;10:2811–2818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4227425</ArticleId><ArticleId IdType="pubmed">25241846</ArticleId></ArticleIdList></Reference><Reference><Citation>Garmaroudi F.S., Marchant D., Hendry R., Luo H., Yang D., Ye X., Shi J., McManus B.M. Coxsackievirus B3 replication and pathogenesis. Future Microbiol. 2015;10:629–653.</Citation><ArticleIdList><ArticleId IdType="pubmed">25865198</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazina E.V., Smidansky E.D., Holien J.K., Harrison D.N., Cromer B.A., Arnold J.J., Parker M.W., Cameron C.E., Petrou S. Amiloride is a competitive inhibitor of coxsackievirus B3 RNA polymerase. J. Virol. 2011;85:10364–10374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196452</ArticleId><ArticleId IdType="pubmed">21795353</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Z., Zhang Y., Huang K., Wang J., Tian H., Song Y., Yang Q., Yan D., Zhu S., Yao M., Wang X., Xu W. Two Coxsackievirus B3 outbreaks associated with hand, foot, and mouth disease in China and the evolutionary history worldwide. BMC Infect. Dis. 2019;19:466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6534883</ArticleId><ArticleId IdType="pubmed">31126252</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y., Chipman P.R., Howitt J., Bator C.M., Whitt M.A., Baker T.S., Kuhn R.J., Anderson C.W., Freimuth P., Rossmann M.G. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat. Struct. Biol. 2001;8:874–878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4152846</ArticleId><ArticleId IdType="pubmed">11573093</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemball C.C., Alirezaei M., Whitton J.L. Type B coxsackieviruses and their interactions with the innate and adaptive immune systems. Future Microbiol. 2010;5:1329–1347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3045535</ArticleId><ArticleId IdType="pubmed">20860480</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B.K., Cho J.H., Jeong P., Lee Y., Lim J.J., Park K.R., Eom S.H., Kim Y.C. Benserazide, the first allosteric inhibitor of Coxsackievirus B3 3C protease. FEBS Lett. 2015;589:1795–1801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094222</ArticleId><ArticleId IdType="pubmed">26022398</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen O.H., Svedin E., Kapell S., Nurminen A., Hytönen V.P., Flodström-Tullberg M. Enteroviral proteases: structure, host interactions and pathogenicity. Rev. Med. Virol. 2016;26:251–267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169145</ArticleId><ArticleId IdType="pubmed">27145174</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W., Huang X., Chen W. The effects of baicalin and baicalein on cerebral ischemia: a review. Aging Dis. 2017;8:850–867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5758355</ArticleId><ArticleId IdType="pubmed">29344420</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao H., Ye J., Gao L., Liu Y. The main bioactive compounds of Scutellaria baicalensis Georgi. for alleviation of inflammatory cytokines: a comprehensive review. Biomed. Pharmacother. 2021;133</Citation><ArticleIdList><ArticleId IdType="pubmed">33217688</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Chen J., Zhang M., Guo W., Feng C., Liu J., Xu L., Gao N., Ma S. Coxsackievirus B: the important agent of hand, foot, and mouth disease. J. Med. Virol. 2023;95</Citation><ArticleIdList><ArticleId IdType="pubmed">36912377</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopacinski A.B., Sweatt A.J., Smolko C.M., Gray-Gaillard E., Borgman C.A., Shah M., Janes K.A. Modeling the complete kinetics of coxsackievirus B3 reveals human determinants of host-cell feedback. Cell Syst. 2021;12:304–323.e13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8112228</ArticleId><ArticleId IdType="pubmed">33740397</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao E.A., Rajan J.V., Aderem A. Caspase-1-induced pyroptotic cell death. Immunol. Rev. 2011;243:206–214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3609431</ArticleId><ArticleId IdType="pubmed">21884178</ArticleId></ArticleIdList></Reference><Reference><Citation>Ming J., Zhuoneng L., Guangxun Z. Protective role of flavonoid baicalin from Scutellaria baicalensis in periodontal disease pathogenesis: a literature review. Complement. Ther. Med. 2018;38:11–18.</Citation><ArticleIdList><ArticleId IdType="pubmed">29857875</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghaddam E., Teoh B.T., Sam S.S., Lani R., Hassandarvish P., Chik Z., Yueh A., Abubakar S., Zandi K. Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci. Rep. 2014;4:5452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4071309</ArticleId><ArticleId IdType="pubmed">24965553</ArticleId></ArticleIdList></Reference><Reference><Citation>Muckelbauer J.K., Kremer M., Minor I., Diana G., Dutko F.J., Groarke J., Pevear D.C., Rossmann M.G. The structure of coxsackievirus B3 at 3.5 A resolution. Structure. 1995;3:653–667.</Citation><ArticleIdList><ArticleId IdType="pubmed">8591043</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A., Morosky S.A., Delorme-Axford E., Dybdahl-Sissoko N., Oberste M.S., Wang T., Coyne C.B. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 2011;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059221</ArticleId><ArticleId IdType="pubmed">21436888</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekoua M.P., Alidjinou E.K., Hober D. Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus. Nat. Rev. Endocrinol. 2022;18:503–516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9157043</ArticleId><ArticleId IdType="pubmed">35650334</ArticleId></ArticleIdList></Reference><Reference><Citation>Oo A., Teoh B.T., Sam S.S., Bakar S.A., Zandi K. Baicalein and baicalin as Zika virus inhibitors. Arch. Virol. 2019;164:585–593.</Citation><ArticleIdList><ArticleId IdType="pubmed">30392049</ArticleId></ArticleIdList></Reference><Reference><Citation>Organtini L.J., Makhov A.M., Conway J.F., Hafenstein S., Carson S.D. Kinetic and structural analysis of coxsackievirus B3 receptor interactions and formation of the A-particle. J. Virol. 2014;88:5755–5765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4019082</ArticleId><ArticleId IdType="pubmed">24623425</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmenberg A.C. Picornaviral processing: some new ideas. J. Cell. Biochem. 1987;33:191–198.</Citation><ArticleIdList><ArticleId IdType="pubmed">3553216</ArticleId></ArticleIdList></Reference><Reference><Citation>Rui W., Li S., Xiao H., Xiao M., Shi J. Baicalein attenuates neuroinflammation by inhibiting NLRP3/caspase-1/GSDMD pathway in MPTP induced mice model of Parkinson's disease. Int. J. Neuropsychopharmacol. 2020;23:762–773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745250</ArticleId><ArticleId IdType="pubmed">32761175</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y.C., Chiou W.F., Chou Y.C., Chen C.F. Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes. Eur. J. Pharmacol. 2003;465:171–181.</Citation><ArticleIdList><ArticleId IdType="pubmed">12650847</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth M.S., Martin J.H. Picornavirus uncoating. Mol. Pathol. 2002;55:214–219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1187181</ArticleId><ArticleId IdType="pubmed">12147709</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Zhang L., Xu Y., Yang D., Zhang L., Yang S., Zhang W., Wang J., Tian S., Yang S., Yuan T., Liu A., Lv Q., Li F., Liu H., Hou B., Peng X., Lu Y., Du G. The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro. Biochem. Pharmacol. 2021;183</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7588320</ArticleId><ArticleId IdType="pubmed">33121927</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone V.M., Ringqvist E.E., Larsson P.G., Domsgen E., Holmlund U., Sverremark-Ekström E., Flodström-Tullberg M. Inhibition of type III interferon expression in intestinal epithelial cells-a strategy used by Coxsackie B virus to evade the host's innate immune response at the primary site of infection? Microorganisms. 2021;9:105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7824802</ArticleId><ArticleId IdType="pubmed">33466313</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Z., Song Y., Li Y., Liu Y., Jiang P., Lin X., Liu G., Song L., Wang H., Xu A. Coxsackievirus B3, Shandong Province, China, 1990-2010. Emerg. Infect. Dis. 2012;18:1865–1867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3559141</ArticleId><ArticleId IdType="pubmed">23092737</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapparel C., Siegrist F., Petty T.J., Kaiser L. Picornavirus and enterovirus diversity with associated human diseases. Infect. Genet. Evol. 2013;14:282–293.</Citation><ArticleIdList><ArticleId IdType="pubmed">23201849</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu Z., Chapman N.M., Hufnagel G., Tracy S., Romero J.R., Barry W.H., Zhao L., Currey K., Shapiro B. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region. J. Virol. 1995;69:4607–4618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189260</ArticleId><ArticleId IdType="pubmed">7609025</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M.J., Yang C.H., Jin Y., Wan C.B., Qian W.H., Xing F., Li X., Liu Y.Y. Baicalin inhibits coxsackievirus B3 replication by reducing cellular lipid synthesis. Am. J. Chin. Med. 2020;48:143–160.</Citation><ArticleIdList><ArticleId IdType="pubmed">31903780</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Wang C., Lu L., Yuan F., He F. Baicalin and baicalein in modulating tumor microenvironment for cancer treatment: a comprehensive review with future perspectives. Pharmacol. Res. 2023;199</Citation><ArticleIdList><ArticleId IdType="pubmed">38061594</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Cai H., Chen Z., Zhang Y., Wu M., Xu X., Yang L. Baicalein alleviates pyroptosis and inflammation in hyperlipidemic pancreatitis by inhibiting NLRP3/Caspase-1 pathway through the miR-192-5p/TXNIP axis. Int. Immunopharmacol. 2021;101(Pt B)</Citation><ArticleIdList><ArticleId IdType="pubmed">34785144</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Qin Y., Wang T., Chen Y., Lang X., Zheng J., Gao S., Chen S., Zhong X., Mu Y., Wu X., Zhang F., Zhao W., Zhong Z. Pyroptosis induced by enterovirus 71 and coxsackievirus B3 infection affects viral replication and host response. Sci. Rep. 2018;8:2887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5811489</ArticleId><ArticleId IdType="pubmed">29440739</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zhao S., Chen Y., Wang T., Dong C., Wo X., Zhang J., Dong Y., Xu W., Feng X., Qu C., Wang Y., Zhong Z., Zhao W. The capsid protein VP1 of coxsackievirus B induces cell cycle arrest by up-regulating heat shock protein 70. Front. Microbiol. 2019;10:1633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6653663</ArticleId><ArticleId IdType="pubmed">31379784</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zhao S., Chen Y., Wang Y., Wang T., Wo X., Dong Y., Zhang J., Xu W., Qu C., Feng X., Wu X., Wang Y., Zhong Z., Zhao W. N-Acetyl cysteine effectively alleviates Coxsackievirus B-induced myocarditis through suppressing viral replication and inflammatory response. Antiviral Res. 2020;179</Citation><ArticleIdList><ArticleId IdType="pubmed">31883926</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z.L., Wang S., Kuang Y., Hu Z.M., Qiao X., Ye M. A comprehensive review on phytochemistry, pharmacology, and flavonoid biosynthesis of Scutellaria baicalensis. Pharm. Biol. 2018;56:465–484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6292351</ArticleId><ArticleId IdType="pubmed">31070530</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong J., Si X., Angeles A., Zhang J., Shi J., Fung G., Jagdeo J., Wang T., Zhong Z., Jan E., Luo H. Cytoplasmic redistribution and cleavage of AUF1 during coxsackievirus infection enhance the stability of its viral genome. FASEB J. 2013;27:2777–2787.</Citation><ArticleIdList><ArticleId IdType="pubmed">23572232</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong J., Zhang J., Si X., Gao G., Mao I., McManus B.M., Luo H. Autophagosome supports coxsackievirus B3 replication in host cells. J. Virol. 2008;82:9143–9153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2546883</ArticleId><ArticleId IdType="pubmed">18596087</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H., Zhai X., Chen Y., Wang R., Lin L., Chen S., Wang T., Zhong X., Wu X., Wang Y., Zhang F., Zhao W., Zhong Z. Protein 2B of coxsackievirus B3 induces autophagy relying on its transmembrane hydrophobic sequences. Viruses. 2016;8:131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4885086</ArticleId><ArticleId IdType="pubmed">27187444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S., Wang Y., Lin L., Si X., Wang T., Zhong X., Tong L., Luan Y., Chen Y., Li X., Zhang F., Zhao W., Zhong Z. Protease 2A induces stress granule formation during coxsackievirus B3 and enterovirus 71 infections. Virol. J. 2014;11:192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4247557</ArticleId><ArticleId IdType="pubmed">25410318</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang H., Lei H., Liu Z., Liu Y., Li Y., Qiu Y., Xu L. Network pharmacology and molecular docking analysis on molecular targets: mechanisms of baicalin and baicalein against hyperuricemic nephropathy. Toxicol. Appl. Pharmacol. 2021;424</Citation><ArticleIdList><ArticleId IdType="pubmed">34044073</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip F., Lai B., Yang D. Role of coxsackievirus B3-induced immune responses in the transition from myocarditis to dilated cardiomyopathy and heart failure. Int. J. Mol. Sci. 2023;24:7717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10178405</ArticleId><ArticleId IdType="pubmed">37175422</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandi K., Musall K., Oo A., Cao D., Liang B., Hassandarvish P., Lan S., Slack R.L., Kirby K.A., Bassit L., Amblard F., Kim B., AbuBakar S., Sarafianos S.G., Schinazi R.F. Baicalein and baicalin inhibit SARS-CoV-2 RNA-dependent-RNA polymerase. Microorganisms. 2021;9:893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8143456</ArticleId><ArticleId IdType="pubmed">33921971</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T., Tang H., Xie L., Zheng Y., Ma Z., Sun Q., Li X. Scutellaria baicalensis Georgi. (Lamiaceae): a review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. J. Pharm. Pharmacol. 2019;71:1353–1369.</Citation><ArticleIdList><ArticleId IdType="pubmed">31236960</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X., Tian L., Wang J., Zheng B., Zhang W. EV71 3C protease cleaves host anti-viral factor OAS3 and enhances virus replication. Virol. Sin. 2022;37:418–426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9243667</ArticleId><ArticleId IdType="pubmed">35504537</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>